In an optimal scenario, production of diverse cytokines and cytotoxins by TCR-T cells upon TCR binding to pHLA ligands imbues them with capacity to directly attack tumor cells, primarily mediated by CD8 cytotoxic T cells that express high levels of cytotoxins (8, 133–135). This evidence concerns the gene CD8A and neoplasm.